Study Links Altered Glycosylation of Immune Cells to Ulcerative Colitis Severity
Two independent research teams have identified separate molecular pathways that impair gut immune function during intestinal inflammation, including ulcerative colitis. One study found that reduced sialylation of immunoglobulin A (IgA) and B cells disrupts mucosal immune homeostasis, while a second found that a gut bacterial molecule, enterobactin, may reduce inflammation by mildly suppressing cellular energy production. Together, the findings highlight the complexity of gut immune dysregulation and suggest novel therapeutic targets for inflammatory bowel disease.
A preprint published on bioRxiv reports that secretory IgA (SIgA) from ulcerative colitis (UC) patients shows a significant reduction in a specific form of sugar modification called (2,6)-sialylation, and that this loss impairs B cells' ability to differentiate into IgA-producing plasma cells and suppress intestinal inflammation. Mouse models of colitis recapitulated this glycophenotype, and functional experiments showed that desialylated B cells were associated with increased neutrophil infiltration and worsened disease. Transcriptomic analyses of UC patient samples pointed to both elevated neuraminidase enzyme activity and reduced availability of sialic acid precursors as drivers of this desialylation. Separately, a study published in the peer-reviewed journal Gut Microbes from the University of Toledo found that enterobactin, an iron-scavenging molecule produced by gut bacteria such as E. coli, can enter mitochondria and reduce their energy output, a process the researchers suggest may calm overactive inflammatory responses in intestinal tissue. A breakdown product of enterobactin, 2,3-dihydroxybenzoic acid (2,3-DHBA), reduced inflammation, strengthened the gut lining, and improved tissue healing in mouse colitis models. The researchers draw a mechanistic parallel to metformin, a widely used diabetes drug that also mildly inhibits mitochondrial respiration, and frame the findings within the concept of mitohormesis, where low-grade mitochondrial stress can enhance cellular resilience. Both studies underscore the growing recognition that gut immunity is shaped not only by immune cells themselves but also by molecular and metabolic factors including glycosylation and microbial metabolites.
What's missing
The bioRxiv sialylation study is a preprint and has not yet undergone formal peer review, which limits confidence in its findings. Neither study has been tested in human clinical trials, and it remains unclear whether the mouse colitis models used in both studies fully replicate human inflammatory bowel disease. The enterobactin study does not address potential off-target effects of systemic mitochondrial inhibition, nor does it clarify what doses or delivery mechanisms would be safe and effective in humans.
What different sources said
- Mirage NewsCenter
Gut Bacteria Molecule May Ease Intestinal Inflammation
- bioRxivCenter
An Altered Glycome Shapes IgA B-Cell Responses and Gut Immunity During Intestinal Inflammation
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.